http://www.pharmacist.com/AM/Templa...mplate=/CM/ContentDisplay.cfm&ContentID=23603
Here's yet another of those ironies... 8)
FDA will review cardiovascular safety of hypertension drug Benicar
The agency emphasized that the benefits of olmesartan in patients with high blood pressure are still believed to outweigh the risks.
Here's yet another of those ironies... 8)
FDA will review cardiovascular safety of hypertension drug Benicar
The agency emphasized that the benefits of olmesartan in patients with high blood pressure are still believed to outweigh the risks.
